Noncollagenous Bone Matrix Proteins, Calcification, and Thrombosis in Carotid Artery Atherosclerosis
Authors:
- 1 August 1999
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 19 (8) , 1852-1861
Abstract
—Advanced atherosclerosis is often associated with dystrophic calcification, which may contribute to plaque rupture and thrombosis. In this work, the localization and association of the noncollagenous bone matrix proteins osteonectin, osteopontin, and osteocalcin with calcification, lipoproteins, thrombus/hemorrhage (T/H), and matrix metalloproteinases (MMPs) in human carotid arteries from endarterectomy samples have been determined. According to the recent American Heart Association classification, 6 of the advanced lesions studied were type V (fibroatheroma) and 16 type VI (complicated). Osteonectin, osteocalcin, and osteopontin were identified by monoclonal antibodies IIIA3A8, G12, and MPIIIB101and antiserum LF-123. Apolipoprotein (apo) AI, B, and E; lipoprotein(a); fibrinogen; fibrin; fragment D/D-dimer; MMP-2 (gelatinase A); and MMP-3 (stromelysin-1) were identified with previously characterized antibodies. Calcium phosphate deposits (von Kossa’s stain) were present in 82% of samples (3 type V and 15 type VI). Osteonectin was localized in endothelial cells, SMCs, and macrophages and was associated with calcium deposits in 33% of type V and 88% of type VI lesions. Osteopontin was distributed similarly to osteonectin and was associated with calcium deposits in 50% of type V and 94% of type VI lesions. Osteocalcin was localized in large calcified areas only (in 17% of type V and 38% of type VI lesions). ApoB colocalized with cholesterol crystals and calcium deposits. Lipoprotein(a) was localized in the intima, subintima, and plaque shoulder. Fibrin (T/H) colocalized with bone matrix proteins in 33% of type V and 69% of type VI lesions. MMP-3 was cytoplasmic in most cells and colocalized with calcium and fibrin deposits. MMP-2 was less often associated with calcification. The results of this study show that osteonectin, osteopontin, and osteocalcin colocalized with calcium deposits with apoB, fibrin, and MMP-3 in advanced, symptomatic carotid lesions. These data suggest that the occurrence of T/H might contribute to dystrophic arterial calcification in the progression and complications of atherosclerosis.Keywords
This publication has 60 references indexed in Scilit:
- Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA proteinNature, 1997
- Tissue Transglutaminase and Factor XIII in Cartilage and Bone RemodelingSeminars in Thrombosis and Hemostasis, 1996
- Degradation of Cross-Linked Fibrin by Matrix Metalloproteinase 3 (Stromelysin 1): Hydrolysis of the γ Gly 404−Ala 405 Peptide BondBiochemistry, 1996
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis.Journal of Clinical Investigation, 1994
- High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify.Journal of Clinical Investigation, 1994
- LP(a) as a marker for coronary heart disease riskClinical Cardiology, 1991
- Structure and Expression of Osteonectin Mrna in Human TissueConnective Tissue Research, 1990
- Atherocalcin, a γ-carboxyglutamic acid containing protein from atherosclerotic plaqueBiochemical and Biophysical Research Communications, 1979